Antitumor effects of ZD6474, a small molecule Vascular endothelial growth factor receptor tyrosine kinase inhibitor, with additional activity against epidermal growth factor receptor tyrosine kinaseCIARDIELLO, Fortunato; CAPUTO, Rosa; TORTORA, Giampaolo et al.Clinical cancer research. 2003, Vol 9, Num 4, pp 1546-1556, issn 1078-0432, 11 p.Article

ZD6474 inhibits vascular endothelial growth factor signaling, angiogenesis, and tumor growth following oral administrationWEDGE, Stephen R; OGILVIE, Donald J; GRAHAM, George A et al.Cancer research (Baltimore). 2002, Vol 62, Num 16, pp 4645-4655, issn 0008-5472Article

ZD6474, an orally available inhibitor of KDR tyrosine kinase activity, efficiently blocks oncogenic RET kinasesCARLOMAGNO, Francesca; VITAGLIANO, Donata; GUIDA, Teresa et al.Cancer research (Baltimore). 2002, Vol 62, Num 24, pp 7284-7290, issn 0008-5472, 7 p.Article

Novel 4-anilinoquinazolines with C-7 basic side chains: Design and structure activity relationship of a series of potent, orally active, VEGF receptor tyrosine kinase inhibitorsHENNEQUIN, Laurent F; STOKES, Elaine S. E; THOMAS, Andrew P et al.Journal of medicinal chemistry (Print). 2002, Vol 45, Num 6, pp 1300-1312, issn 0022-2623Article